Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-08 | "Dr. Hill earned his Pharm.D. from the University of Southern California and completed a post-doctoral program..." |
| 2015-03-09 | "Dr. Hill earned his Pharm.D. from the University of Southern California and completed a post-doctoral program..." |
| 2016-03-15 | "Dr. Hill has more than 25 years of academic and pharmaceutical industry experience in new product assessment and clinical trial design and execution... Dr. Hill earned his Pharm.D." |
| 2017-03-22 | "Dr. Hill earned his Pharm.D. from the University of Southern California and completed a post-doctoral program at the Veterans Administration Medical Center, San Diego" |
| 2018-03-16 | "Dr. Hill earned his Pharm.D. from the University of Southern California and completed a post-doctoral program..." |
| 2019-03-21 | "Dr. Hill has more than 30 years of academic and pharmaceutical industry experience in new product assessment and clinical trial design and execution... Dr. Hill earned his Pharm.D. from the University of Southern California" |
| 2020-04-14 | "Dr. Hill earned his Pharm.D. from the University of Southern California and completed a post-doctoral program..." |
| 2021-03-26 | "Dr. Hill earned his Pharm.D. from the University of Southern California and completed a post-doctoral program..." |
| 2022-03-15 | "Dr. Hill has more than 30 years of academic and pharmaceutical industry experience in new product assessment and clinical trial design and execution... Dr. Hill earned his Pharm.D. from the University of Southern California" |
| 2023-03-29 | "Dr. Hill has more than 30 years of academic and pharmaceutical industry experience... Dr. Hill earned his Pharm.D. from the University of Southern California..." |
| 2024-04-10 | "Dr. Hill has more than 30 years of academic and pharmaceutical industry experience ... Since September 2020, Dr. Hill has served as Chief Development Officer at Mopac Biologics, a company specializing in development of computationally derived proteins..." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-14